What is Elite Pharmaceuticals Forward Dividend Yield %?
As of today (2024-04-27), the Forward Annual Dividend Yield of Elite Pharmaceuticals is 0.00%.
As of today (2024-04-27), the Trailing Annual Dividend Yield of Elite Pharmaceuticals is 0.00%.
ELTP's Forward Dividend Yield % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.89 * Ranked among companies with meaningful Forward Dividend Yield % only.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
Competitive Comparison of Elite Pharmaceuticals's Forward Dividend Yield %
For the Drug Manufacturers - Specialty & Generic subindustry, Elite Pharmaceuticals's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Elite Pharmaceuticals's Forward Dividend Yield % Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Elite Pharmaceuticals's Forward Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Elite Pharmaceuticals's Forward Dividend Yield % falls into.
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Elite Pharmaceuticals Forward Dividend Yield % Related Terms
Thank you for viewing the detailed overview of Elite Pharmaceuticals's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.
Elite Pharmaceuticals (Elite Pharmaceuticals) Business Description
Elite Pharmaceuticals Inc is a pharmaceutical company. It is principally engaged in the development and manufacture of oral, controlled-release products, using proprietary know-how and technology. The company's operating segment includes Abbreviated New Drug Applications (ANDA) and New Drug Applications (NDA). It generates maximum revenue from the ANDA segment. The company focuses on developing pain management products; manufacturing a line of generic pharmaceutical products with approved Abbreviated New Drug Applications; developing additional generic pharmaceutical products; development of other products in its pipeline including the products with its partners; and commercialization of new products.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ELTP has been successfully added to your